These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 7166352)

  • 1. Some remarks on the recent bacteriological research on tuberculosis.
    Daddi G; Lucchesi M; Zubiani M
    Indian J Chest Dis Allied Sci; 1982; 24(2-3):164-9. PubMed ID: 7166352
    [No Abstract]   [Full Text] [Related]  

  • 2. [Drug resistance of tubercle bacilli isolated from sputum in previously untreated pulmonary tuberculosis. 3].
    Nakai H; Maekawa N; Nakanishi M; Kawai M; Naito M
    Bull Chest Dis Res Inst Kyoto Univ; 1971 Jan; 4(1):15-24. PubMed ID: 5005481
    [No Abstract]   [Full Text] [Related]  

  • 3. [Comparative bacteriological study of sputum and resected lung particles in patients with tuberculosis].
    Fisher EF; Gaĭnutdinova NSh; Liadunkina MM; Mulik MI
    Lab Delo; 1969; 5():298-300. PubMed ID: 4185264
    [No Abstract]   [Full Text] [Related]  

  • 4. Chemotherapy of chronic pulmonary tuberculosis with polyresistant bacteria with reference to ethambutol and capreomycin.
    Radenbach KL
    Scand J Respir Dis Suppl; 1968; 65():195-206. PubMed ID: 4978461
    [No Abstract]   [Full Text] [Related]  

  • 5. [Evaluation of BK positivity and resistance of Mycobacterium tuberculosis 1983-1986 in areas of Bosnia and Herzegovina].
    Vinik LK; Konjicija A; Sutić N; Psorn-Rajs A; Matić M; Arslanagić N
    Plucne Bolesti; 1988; 40(1-2):32-5. PubMed ID: 3141940
    [No Abstract]   [Full Text] [Related]  

  • 6. [Possibility of the intensification of tuberculosis chemotherapy and its limits].
    Naito M; Kanai K; Kondo E; Yamashita H; Matsui K
    Kekkaku; 1969 Nov; 44(11):377-93. PubMed ID: 4982567
    [No Abstract]   [Full Text] [Related]  

  • 7. [Importance of directed bronchial secretion aspiration for the bacteriological diagnosis of tuberculosis].
    Ewert EG
    Z Tuberk Erkr Thoraxorg; 1967; 126(3):162-8. PubMed ID: 4971151
    [No Abstract]   [Full Text] [Related]  

  • 8. [Changes in surgical treatment of pulmonary tuberculosis in recent 6 years. A comparative study between preoperative culture positive and negative cases].
    Kekkaku; 1984 Aug; 59(8):467-74. PubMed ID: 6438384
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical significance of Mycobacterium tuberculosis polydrug resistance in chronic destructive forms of pulmonary tuberculosis].
    Bialik IB; Klimenko MT
    Probl Tuberk; 1980 Oct; (10):68-70. PubMed ID: 6776517
    [No Abstract]   [Full Text] [Related]  

  • 10. A short term survey of mycobacteria isolated from Kentucky tuberculosis hospital patients.
    Huempfner HR; Watson KA
    J Ky Med Assoc; 1968 Mar; 66(3):263-6 passim. PubMed ID: 5644197
    [No Abstract]   [Full Text] [Related]  

  • 11. [Study of the Candida genus as associated flora in pulmonary tuberculosis].
    Del Rey Calero J; Casal Roman M; Martinez Alcazar P
    Rev Clin Esp; 1974 Jul; 134(2):175-80. PubMed ID: 4438723
    [No Abstract]   [Full Text] [Related]  

  • 12. [Approaches to combined therapy of pulmonary tuberculosis in adolescents excreting drug-resistant Mycobacterium tuberculosis].
    Firsova VA; Rusakova LI; Grigor'eva ZP; Ryzhova AP; Iatskova TV; Poluéktova FG
    Probl Tuberk; 2001; (1):28-30. PubMed ID: 11337776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Study of tubercle bacilli from persistently sputum-positive patients treated with antituberculosis drugs for long duration in 3 Shanghai districts].
    Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1983 Aug; 6(4):222-4. PubMed ID: 6418491
    [No Abstract]   [Full Text] [Related]  

  • 14. [Endocavernous treatment of caverns with atypical Mycobacteria].
    Neef W
    Z Erkr Atmungsorgane Folia Bronchol; 1970 Jun; 131(5):385-9. PubMed ID: 5210837
    [No Abstract]   [Full Text] [Related]  

  • 15. [Determination of adequate drug combinations in the treatment of cavernous tuberculosis].
    Seri I
    Prax Pneumol; 1971 Apr; 25(4):211-9. PubMed ID: 4995326
    [No Abstract]   [Full Text] [Related]  

  • 16. Bacteriological mechanisms in recent controlled chemotherapy studies.
    Mitchison DA
    Bull Int Union Tuberc; 1970 Jun; 43():322-31. PubMed ID: 5425562
    [No Abstract]   [Full Text] [Related]  

  • 17. [An investigation on multiple drug resistance of the rifampin resistant strains of Mycobacterium tuberculosis].
    Kuang T; Jin G; Song P; Li W; Wang Z
    Wei Sheng Wu Xue Bao; 1998 Apr; 38(2):152-4. PubMed ID: 12549378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative bacillary response to treatment in Mycobacterium tuberculosis infected and M. africanum infected adults with pulmonary tuberculosis.
    Joloba ML; Johnson JL; Namale A; Morrissey A; Assegghai AE; Rüsch-Gerdes S; Mugerwa RD; Ellner JJ; Eisenach KD
    Int J Tuberc Lung Dis; 2001 Jun; 5(6):579-82. PubMed ID: 11409588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The rate of destruction of sensitive mycobacteria as a factor in the development of resistance in cavitating pulmonary tuberculosis].
    Seri I
    Prax Pneumol; 1974 May; 28(5):256-62. PubMed ID: 4210051
    [No Abstract]   [Full Text] [Related]  

  • 20. [Disappearance rate of bacteria as a parameter of the efficacy of tuberculostatic treatment of cavitating lung tuberculosis].
    Seri I
    Prax Pneumol; 1972 Jan; 26(1):12-22. PubMed ID: 5011607
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.